PPAG News


83 Articles found
Page 1 of 17 • Next

Posted by: Matthew Helms on Apr 19, 2018

The Pediatric Pharmacy Advocacy Group (PPAG), a global authority on neonatal pharmacy information, has agreed to license its comprehensive content library to eBroselow, makers of the SafeDose application suite. For more information, please see the press release: www.ebroselow.com/ebroselow-announces-agreement-share-ppag-knowledge-base/

 

Posted by: Matthew Helms on Apr 19, 2018

PPAG is pleased to announced new Fellows in the Pediatric Pharmacy Advocacy Group (FPPAG). The Fellows program recognizes pediatric pharmacists who distringuish themselves in the profession and demonstrate sustained practice excellence, contribute to the total body of knowledge, educate and mentor future members of the profession, and demonstrate active leadership in professional activities. 

Jared Cash, PharmD, MBA, BCPS, FPPAG

Jared Cash is the Director of Pharmacy at Intermountain Healthcare’s Primary Children’s Hospital is Salt Lake City, UT. He is also an adjunct Assistant Professor at the University of Utah College of Pharmacy. He received his Bachelors of Pharmacy from the University of Utah in 1996 and his Doctor of Pharmacy from the University of Florida in 1996. Dr. Cash is a Board Certified Pharmacotherapy Specialist. He recently completed a Masters of Business Administration. During his 26 years at Primary Children’s Hospital he has been a Pediatric Intensive Care Pharmacist, PALS instructor, Pediatric Intensive Care Team Leader, Clinical Coordinator, and a Pharmacy Manager. Dr. Cash served on the PPAG Board of Directors from 2011-2017, as President in 2015-2016.

David Knoppert, BScPh, FPPAG

David Knoppert completed a Degree in Honors Biology in 1976, then a Bachleor's Degree in Education in 1977. He graduated with a BScPhm from the University of Toronto in 1980, then completed a Hospital Residency in London, Ontario during 1980-81. In 2004 he completed a MSc degree in Clinical Epidemiology at Western University. From 1981 to 1983 he was a staff pharmacist at The Hospital for Sick Children in Toronto. In 1986 Mr. Knoppert completed a MScPhm at The University of Toronto. 1986 he began as an NICU Pharmacist and Drug Information Pharmacist at St Joseph's Hospital in London, ON. In 1989 he became the Clinical Coordinator, and continued to practice in the NICU. In 2011 Mr. Knoppert followed the Perinatal Program Transfer to London Health Sciences Centre where he became the Pediatric Clinical Coordinator and Residency Coordinator until he retired in November of 2013. In 2014 he became a part time Coordinator for Pharmacy Students from the University of Waterloo. At that time he also joined the Board for the Canadian Council on Continuing Education in Pharmacy (CCCEP). He continues to be a Board member of the International Alliance for Better Medicines in Children (IABMC). Mr. Knoppert served at President of PPAG in 2011-12 during his term on the Board between 2008-13.

Jamie Miller, PharmD, BCPS, BCPPS, FPPAG

Jamie Miller is an Associate Professor in the Department of Pharmacy Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy and Adjunct Associate Professor of Pediatrics at the OU College of Medicine. Dr. Miller currently practices as a Clinical Pharmacy Specialist in the Neonatal Intensive Care Unit at the Children’s Hospital at OU Medical Center in Oklahoma City. In addition, Dr. Miller is the Residency Program Director for the PGY1 Pharmacy Residency at the University of Oklahoma College of Pharmacy and OU Medical Center. Dr. Miller received her Doctor of Pharmacy degree from Southwestern Oklahoma State University College of Pharmacy. Following graduation, she completed a PGY1 Pharmacy Residency and PGY2 Pediatric Pharmacy Residency at the University of Oklahoma College of Pharmacy and OU Medical Center. Among her professional affiliations, she is a member of the Pediatric Pharmacy Advocacy Group, American Society of Health-System Pharmacists, and American Association of Colleges of Pharmacy. Her research/scholarship focuses on sedation/analgesia and drug withdrawal in critically-ill neonates, infants, and children.

Katherine Pham, PharmD, FPPAG

Kathy Pham, PharmD is the Director of Policy and Professional Affairs at the American College of Clinical Pharmacy. Her career path as taken an interesting turn from clinical practice to advocacy to public policy work. Her clinical career started after receiving her BSPharm and Pharm.D. degrees from Rutgers, the State University of NJ. She then completed a Pharmacy Practice Residency with Emphasis in Pediatrics at the University of Illinois at Chicago. She went on to teach as Assistant Professor of Pharmacy Practice at Long Island University. She further developed her pediatric clinical practice at St Joseph's Children's Hospital in NJ before her 8 year career at Children's National Medical Center, where she was the NICU Clinical Specialist as well as the Residency Program Director of the PGY1 Pharmacy and PGY2 Pediatric Pharmacy Residency programs. She became Board-certified in Pediatric Pharmacotherapy in 2017. She then pursued a unique opportunity as the Senior Officer of the Drug Safety Project at the Pew Charitable Trusts before recently joining ACCP at the start of 2018.

Hanna Phan, PharmD, FPPAG

Dr. Hanna Phan is an Associate Professor in Pharmacy Practice and Science at the College of Pharmacy and in the Department of Pediatrics at the College of Medicine at the University of Arizona (UA). She is also an Associate Research Scientist for the UA Asthma and Airway Disease Research Center and Faculty for the UA Pediatric Pulmonary Center (PPC). Dr. Phan practices as a Clinical Pharmacy Specialist in Pediatric Pulmonary Medicine at Banner University Medical Center-Tucson, practicing in both Pediatric Pulmonary Clinics and the Adult CF center. She established the Post-Graduate Year 2 (PGY-2) Pediatric Pharmacy Residency at Banner University Medical Center–Tucson, Diamond Children’s in 2009 and served as Residency Program Director through 2015. Dr. Phan earned her Doctor of Pharmacy (PharmD) from the University of Michigan and completed a Postdoctoral Fellowship in Pediatric Pharmacotherapy at The Ohio State University. Dr. Phan has received state and national recognition for her clinical practice, professional service, and research from organizations such as the Arizona Pharmacy Association, Pediatric Pharmacy Advocacy Group (PPAG), American College of Clinical Pharmacy (ACCP), and the American Society of Health-System Pharmacists (ASHP) Foundation. She was a Director-at-Large on the PPAG board from 2014-2017 and has previously chaired the PPAG Research Committee (2013-2014) and is currently a Co-Chair for the PPAG Recertification Advisory Committee. She has given invited lectures nationally and internationally, and authored various book chapters and peer-reviewed manuscripts in the area of pediatric pharmacotherapy. Dr. Phan’s current research interests include patient-caregiver education and medication adherence, pediatric medication safety, and interprofessional care of children with chronic conditions such as cystic fibrosis and asthma.

 

Posted by: Matthew Helms on Apr 18, 2018

George Giacoia, MD has been named the 2018 recipient of the Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics. The Award recognized significant and sustained contributions toward the improvement of children’s health thought the expansion of the field of pediatric pharmacology and therapeutics.

Dr. Giacoia is currently the Program Director of the Pediatric Clinical and Developmental Pharmacology Training Network at the Eunice Kennedy Shiver National Institute of Child Health and Human Development (NICHD), a division of the National Institutes of Health. He is also the Program Director for the US Pediatric Formulations Initiative, a program he helped develop. Prior to his current appointment, he served as the Program Director for the Pediatric Pharmacology Research Unit Network, also a program he initiated. During his distinguished 20-year career at the NIH, Dr. Giacoia developed the US Pediatric Therapeutics Initiative under the Best Pharmaceuticals for Children Act (BPCA). He also spearheaded the Newborn Initiative in partnership with the FDA.

Prior to his service at the NICHD, for nearly 20 years Dr. Giacoia was a Professor of Pediatrics and Division Head of Neonatology and the University of Oklahoma College of Medicine in Tulsa, and Director of the Eastern Oklahoma Perinatal Center at St. Francis Hospital. He also was the Director of the Division of Neonatology and Buffalo Children’s Hospital. Dr. Giacoia was a physician and Director of Nurseries at DeWitt Army Hospital, Baltimore City Hospitals, and Johns Hopkins Hospitals. In addition to serving on the faculty at the University of Oklahoma, Dr. Giacoia has held faculty appointments at Georgetown University, the State University of New York at Buffalo, and Johns Hopkins University.

Dr. Giacoia is a Fellow of the American Academy of Pediatrics and Associate Fellow of the American College of Obstetricians & Gynecologists. He is a member of the Drug Information Association and the American Society of Clinical Pharmacology and Therapeutics. Dr. Giacoia has received two NICHD Merit Awards.

The 2018 Yaffe Award Lecture will be given during the 27th Annual PPAG Meeting in Salt Lake City, UT on April 27, 2018.

About PPAG
The mission of PPAG is to advocate for safe and effective medication use in children through education, collaboration, and research. The association’s 1,400 members include pharmacists, pharmacy residents, pharmacy technicians, and pharmacy students who practice in various inpatient and outpatient care settings.
For more information about the organization, go to www.ppag.org

For media inquiries, contact:
Matthew Helms, PPAG Executive Director
T. 901-820-4434
E. matthew.helms@ppag.org

 

Posted by: Matthew Helms on Apr 18, 2018

Jared Cash, PharmD, FPPAG has been named the 2018 recipient of the Richard A. Helms Award of Excellence in Pediatric Pharmacy Practice. The Helms Award recognizes exemplary pediatric patient care, sustained and meritorious contributions to pediatric pharmacy practice and PPAG, contributions to education, and ​contributions of new knowledge.

Dr. Cash is currently the Director of Pharmacy at Intermountain Healthcare’s Primary Children’s Hospital is Salt Lake City, UT. He is also an adjunct Assistant Professor at the University of Utah College of Pharmacy. His current position covers Primary Children's Hospital as well as a large Behavioral Health Campus, Riverton Surgery and Clinic Center, Layton Imaging Pediatrics, and all pediatric and NICU patients seen in 22 Intermountain Healthcare hospitals. During his 26 years at Primary Children’s Hospital he has been a Pediatric Intensive Care Pharmacist, PALS instructor, Pediatric Intensive Care Team Leader, Clinical Coordinator, and a Pharmacy Manager.

He received his Bachelors of Pharmacy from the University of Utah and his Doctor of Pharmacy from the University of Florida. Dr. Cash is a Board Certified Pharmacotherapy Specialist. He recently completed his Masters of Business Administration. In 2018, he was named Fellow in the Pediatric Pharmacy Advocacy Group.

An expert in pediatric medication safety, Dr. Cash was formally involved with the Institute of Safe Medication Practice (ISMP) as a pediatric consultant and completed on-site ISMP assessments at over twenty pediatric centers. He is also on the Editorial Advisory Panel for Lexi-Comp’s Pediatric and Neonatal Dosage Handbook and database.

Dr. Cash has been a member of PPAG for 21 years. He served on PPAG Board of Directors from 2011-2017. He served as the 2015-2016 PPAG President. Dr. Cash was instrumental in developing the Drug Development Committee, and he encouraged collaborative agreements and external relationships with like-minded organizations, like the American Academy of Pediatrics.

He and his colleagues have been awarded three PPAG Best Practice awards throughout the years:

  1. 2007- A Continuous Approach to Improving Pediatric Outcomes through Intravenous and Oral Medication Standardization
  2. 2009- Blinded Volume Verification in a Pediatric Bar-Code Medication Administration System to Reduce Wrong Dose Administration Errors
  3. 2017- Cystic Fibrosis Medication Adherence Measured by an Integrated Health-System Specialty Pharmacy Team

 

During his tenure at Primary Children’s Hospital, Dr. Cash integrated a pharmacist into a new Trauma Response Team and eventual hospital designation as Trauma One Center in 1998. He designed and developed standardized weight-based medication Trauma sheets still used today and part of code blue responses. Dr. Cash has improved pharmacy practice, including implementing an Antibiotic Stewardship Pharmacist, Cystic Fibrosis Clinic Pharmacist, second Transplant Pharmacist, Outpatient Behavioral Health Pharmacist, IT Technician, and IT Chemo Pharmacist.

The 2018 Helms Lecture will be presented during the 27th Annual PPAG Meeting on April 27, 2018 in Salt Lake City, UT.

About PPAG
The mission of PPAG is to advocate for safe and effective medication use in children through education, collaboration, and research. The association’s 1,400 members include pharmacists, pharmacy residents, pharmacy technicians, and pharmacy students who practice in various inpatient and outpatient care settings. For more information about the organization, go to www.ppag.org

For media inquiries, contact:
Matthew Helms, PPAG Executive Director
T. 901-820-4434
E. matthew.helms@ppag.org

 

Posted by: Matthew Helms on Mar 7, 2018

It is with great sadness, to share with the PPAG Community, the passing of Dr. Helen Fiechtner. As many of you know, she has struggled in her health for the last seven years. She passed peacefully, surrounded by her family on Monday afternoon.

Dr. Fiechtner became a member of PPAG in 1991 and served on various Committees, including advocacy and membership. In 1997 she was elected to the Board of Directors, serving through 2000. Helen was one of 6 co-authors of the Consumer’s Guide book to Children’s Prescription Medications published by PPAG in 1997 and 2001. She was recognized in the inaugural class of PPAG Fellows in 2009.

After graduating with her BS in Pharmacy from South Dakota State University, she earned her PharmD degree from the University of Texas at Austin. Dr. Fiechtner completed her residency training at the University of Texas Health Science Center. Following residency, she served as Assistant Professor with the College of Pharmacy at North Dakota State University and as a Pediatric Clinical Pharmacist at St. Luke’s Hospital in Fargo, ND. In 1982 she moved to Rochester, MN where she worked at St. Mary’s Hospital as a staff pharmacist in the decentralized areas of Pediatric/Neonatology, Adult Medical Intensive Care, and Cardiac Transplant/CV Surgery Intensive Care. In 1991, Dr. Fiechtner moved to her most recent position with the College of Pharmacy at South Dakota State University and as a Pediatric Clinical Pharmacist at Sanford Children’s Hospital (Sioux Valley Hospital). Progressing through the academic ranks, she reached full professor in 1998. Throughout her career, Dr. Fiechtner was active in improving pharmaceutical care to the pediatric patients. "Helen had a great love for the many premies, newborns and children she helped care for during her pharmacy practice. She loved teaching and especially loved working with the many students who had ambition and worked hard."

Not only was Dr. Fiechtner's career most significant and impactful, the contributions Helen made in the pediatric pharmacy community came quietly in behind-the-scenes, kind-hearted, and humble gestures to her friends and colleagues. Her support for the pediatric pharmacy community will be forever remembered. Examples of her selflessness include sending handwritten notes to fellow pediatric pharmacists for a recent accomplishment and sending “pediatric goodie boxes” to struggling young practitioners in need of a pick-me-up. Filled with crayons, coloring books, bubble solution, play-doh, etc. and a personal, handwritten note, these boxes would be a happy surprise for newer practitioners and are remembered by many PPAG members, as a symbol of friendship, love, and generosity.

Dr. Helen Fiechtner will be forever remembered and will be missed by our pediatric pharmacy community, our family.

Helen Beckman Fiechtner
May 4, 1953 - March 5, 2018

http://www.georgeboom.com/sitemaker/sites/George3/obit.cgi?user=77250913_HFiechtner


Page 1 of 17 • Next